The ICRS has been renamed into “International Cartilage Regeneration & Joint Preservation Society”
16/04/2018 MACAU, China / ZURICH, Switzerland, – During the 14th Member’s General Assembly, hold in Macau, China last week, the ICRS members have approved to change their society name to “International Cartilage Regeneration & Joint Preservation Society”
In a few days, the 14th ICRS World Congress in Macau will finally take world center stage of the latest clinical research and basic science in cartilage regeneration & joint preservation.
The ICRS & ON Foundation are happy to announce the winners of the upcoming Travelling Fellowship 2018:
ICRS Member’s General Assembly 2018
Wednesday, April 11, 2018 from 17:30 – 18:30
Sheraton Convention Center Macau, Room Almati 1
It is with great sadness that we note the sudden passing of our friend and long-time ICRS Fellow Member Prof. Dr. James Richardson from Robert Jones & Agnes Hunt Orthopaedic Hospital, Oswestry. James has been a longtime active member of our society and great contributor to our field for many years. We will miss him greatly and our thoughts and prayers go out to his family and friends.
Condolences can be sent to Anthony Hollander at A.Hollander(at)liverpool.ac.uk. he will collect and foward in due time.
Ken Zaslav, President ICRS
Are you planning to attend the ICRS World Congress in Macau? Apply for one of ten education grants (500 Euro) or one of two education scholarships (2000 Euro) provided by ON Foundation, the orthoregeneration network, for ICRS members in good standing. Application deadline is February 22, 2018.
On behalf of the ICRS Fellowship, Scholarship & Research Grant Committee and the ON Foundation, dedicated to advance the field of orthopaedic tissue regeneration, we invite ICRS members below age 40 to apply for the ICRS & ON Foundation – Research Travelling Fellowship 2018 .
There are still a few tickets available for the “Lectures only” part of the meeting…
The ICRS Registry Steering Committee is delighted to confirm that the Japanese translation of the Patient Portal is now live and can be accessed immediately through the ICRS Patient Registry
Save up to 250 Euros • First Come – First Serve Policy – Limited to 48 vacancies for the Wet-Lab • Reduced Student / Resident Fees (available until October 31, 2017)
BEDFORD, Mass.–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today announced that regulatory authorities in Australia granted approval to MONOVISC®, Anika’s single injection viscosupplement for the treatment of pain associated with osteoarthritis of all synovial joints, including the hip and knee.
Clinical trial evidence shows that ACI can improve the symptoms of articular cartilage defects of the knee. There is evidence that it is likely to be more successful in people who haven’t had any previous knee repair surgery, and in people who have very little osteoarthritic damage in the knee. But, it is unclear how well ACI works in the long term compared with microfracture, the most commonly used alternative treatment.
